| Autor: |
Chokevittaya P; Division of Allergy and Clinical Immunology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Vichara-Anont I; Division of Allergy and Clinical Immunology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Krikeerati T; Division of Allergy and Clinical Immunology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Sompornrattanaphan M; Division of Allergy and Clinical Immunology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Ruangchira-Urai R; Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Suratannon N; Faculty of Medicine, Division of Allergy, Immunology and Rheumatology, Department of Pediatrics, Center of Excellence for Allergy and Clinical Immunology, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand., Thongngarm T; Division of Allergy and Clinical Immunology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Wongsa C; Division of Allergy and Clinical Immunology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. |
| Abstrakt: |
Competing Interests: Dr Sompornrattanaphan has received honoraria for scientific lectures from A. Menarini, Astra-Zeneca, GSK, Takeda, and Viatris. Dr Thongngarm has received honoraria for scientific lectures from A. Menarini, Astra-Zeneca, GSK, Novartis, Sanofi, Takeda, and Viatris and served on the advisory boards for Sanofi and Viatris. Dr Wongsa, has received honoraria for scientific lectures from A. Menarini, Astra-Zeneca, GSK, Takeda, and Viatris. Drs Chokevittaya, Vichara-anont, Krikeerati, Ruangchira-urai, and Suratannon have no conflicts of interest to declare. |
